Adenosine concentration in the porcine coronary artery wall and A2A receptor involvement in hypoxia-induced vasodilatation

Journal of Physiology

Volumn 570, Issue 2, 2006, Pages 375-384

  Frøbert, Ole ^a,b   Haink, Gesine ^c   Simonsen, Ulf ^b   Gravholt, Claus H ^d   Levin, Max ^e   Deussen, Andreas ^c  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

^e UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; 9 (2 HYDROXY 3 NONYL)ADENINE; ADENOSINE; ADENOSINE A2 RECEPTOR; ADENOSINE A2 RECEPTOR ANTAGONIST; ADENOSINE DEAMINASE; ADENOSINE KINASE; CARBON 14; GLUCOSE; LACTIC ACID; PROSTAGLANDIN F2 ALPHA; PYRUVIC ACID; ADENOSINE A2A RECEPTOR; CARBON 13; CHEMICAL COMPOUND; IODOTUBERICIDINE; N (4 CYANOPHENYL) 2 [4 (2,3,6,7 TETRAHYDRO 2,6 DIOXO 1,3 DIPROPYL 1H PURIN 8 YL)PHENOXY]ACETAMIDE; N NITROBENZYLTHIOINOSINE; UNCLASSIFIED DRUG; ACETAMIDE DERIVATIVE; ADENOSINE A2B RECEPTOR; LACTIC ACID DERIVATIVE; N (4 CYANOPHENYL) 2 (4 (2,3,6,7 TETRAHYDRO 2,6 DIOXO 1,3 DIPROPYL 1H PURIN 8 YL) PHENOXY)ACETAMIDE; N-(4-CYANOPHENYL)-2-(4-(2,3,6,7-TETRAHYDRO-2,6-DIOXO-1,3-DIPROPYL-1H-PURIN-8-YL)-PHENOXY)ACETAMIDE; PURINE DERIVATIVE; TRIAZINE DERIVATIVE; TRIAZOLE DERIVATIVE;

ANIMAL TISSUE; ARTERY DIAMETER; ARTERY WALL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY DILATATION; DIALYSATE; DIALYSIS CATHETER; DIALYSIS MEMBRANE; HEART MUSCLE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPOXIA; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MYOGRAPHY; NONHUMAN; OXYGENATION; PRIORITY JOURNAL; RECEPTOR INTRINSIC ACTIVITY; SPECTROPHOTOMETRY; SWINE; TUNICA MEDIA; ANIMAL CELL; BLOOD VESSEL DIAMETER; CONCENTRATION (PARAMETERS); CORONARY ARTERY; PIG; PROTEIN FUNCTION; VASODILATATION; ANIMAL; ANOXIA; CHEMISTRY; CORONARY BLOOD VESSEL; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; IN VITRO STUDY; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ACETAMIDES; ADENOSINE; ADENOSINE DEAMINASE; ADENOSINE KINASE; ANIMALS; ANOXIA; CORONARY VESSELS; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOSE; LACTATES; PURINES; PYRUVIC ACID; RECEPTOR, ADENOSINE A2A; RECEPTOR, ADENOSINE A2B; SWINE; TRIAZINES; TRIAZOLES; VASODILATION;

EID: 33644873094     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2005.100115     Document Type: Article

References (46)

1. Bache RJ, Dai XZ, Schwartz JS & Homans DC (1988). Role of adenosine in coronary vasodilation during exercise. Circ Res 62, 846-853.
2. Barron JT & Gu L (2000). Energetic effects of adenosine on vascular smooth muscle. Am J Physiol Heart Circ Physiol 278, H26-H32.
3. Berne RM (1963). Cardiac nucleotides in hypoxia: Possible role in regulation of coronary blood flow. Am J Physiol 204, 317-322.
4. Bjornheden T, Evaldsson M & Wiklund O (1996). A method for the assessment of hypoxia in the arterial wall, with potential application in vivo. Arterioscler Thromb Vasc Biol 16, 178-185.
5. Busse R, Pohl U, Kellner C & Klemm U (1983). Endothelial cells are involved in the vasodilatory response to hypoxia. Pflugers Arch 397, 78-80.
6. Deussen A (2000). Metabolic flux rates of adenosine in the heart. Naunyn Schmiedebergs Arch Pharmacol 362, 351-363.
7. 2. J Mol Cell Cardiol 23, 495-504.
8. Deussen A, Stappert M, Schafer S & Kelm M (1999). Quantification of extracellular and intracellular adenosine production: Understanding the transmembranous concentration gradient. Circulation 99, 2041-2047.
9. Djurhuus CB, Gravholt CH, Nielsen S, Pedersen SB, Moller N & Schmitz O (2004). Additive effects of cortisol and growth hormone on regional and systemic lipolysis in humans. Am J Physiol Endocrinol Metab 286, E488-E494.
10. Downey HF, Crystal GJ, Bockman EL & Bashour FA (1982). Nonischemic myocardial hypoxia: Coronary dilation without increased tissue adenosine. Am J Physiol 243, H512-H516.
11. Duncker DJ, Stubenitsky R & Verdouw PD (1998). Role of adenosine in the regulation of coronary blood flow in swine at rest and during treadmill exercise. Am J Physiol 275, H1663-H1672.
12. Fenton RA & Dobson JG Jr (1987). Measurement by fluorescence of interstitial adenosine levels in normoxic, hypoxic, and ischemic perfused rat hearts. Circ Res 60, 177-184.
13. Flood A & Headrick JP (2001). Functional characterization of coronary vascular adenosine receptors in the mouse. Br J Pharmacol 133, 1063-1072.
14. Frøbert O, Bagger JP, Simonsen U, Lund S & Gravholt CH (2004). Insulin increases glycolysis without further vasodilation in porcine coronary arteries exposed to hypoxia. Clin Sci (Lond) 107, 213-220.
15. Frøbert O, Buus CL & Rembold CM (2005). HSP20 phosphorylation and interstitial metabolites in hypoxia-induced dilation of swine coronary arteries. Acta Physiol Scand 184, 37-44.
16. 2+-induced coronary artery constriction. Acta Physiol Scand 165, 379-385.
17. Frøbert O, Mikkelsen EO, Bagger JP & Gravholt CH (2002). Measurement of interstitial lactate during hypoxia-induced dilatation in isolated pressurised porcine coronary arteries. J Physiol 539, 277-284.
18. Gamboa A, Ertl AC, Costa F, Farley G, Manier ML, Hachey DL, Diedrich A & Biaggioni I (2003). Blockade of nucleoside transport is required for delivery of intraarterial adenosine into the interstitium: Relevance to therapeutic preconditioning in humans. Circulation 108, 2631-2635.
19. Gewirtz H, Olsson RA & Most AS (1987). Role of adenosine in mediating the coronary vasodilative response to acute hypoxia. Cardiovasc Res 21, 81-89.
20. Haink G & Deussen A (2003). Liquid chromatography method for the analysis of adenosine compounds. J Chromatogr B Anal Technol Biomed Life Sci 784, 189-193.
21. Hall JL, Van Wylen DG, Pizzurro RD, Hamilton CD, Reiling CM & Stanley WC (1995). Myocardial interstitial purine metabolites and lactate with increased work in swine. Cardiovasc Res 30, 351-356.
22. Kemp BK & Cocks TM (1999). Adenosine mediates relaxation of human small resistance-like coronary arteries via A2B receptors. Br J Pharmacol 126, 1796-1800.
23. Kerkhof CJ, Van Der Linden PJ & Sipkema P (2002). Role of myocardium and endothelium in coronary vascular smooth muscle responses to hypoxia. Am J Physiol Heart Circ Physiol 282, H1296-H1303.
24. Kobayashi S, Conforti L, Pun RY & Millhorn DE (1998). Adenosine modulates hypoxia-induced responses in rat PC12 cells via the A2A receptor. J Physiol 508, 95-107.
25. Kobayashi S & Millhorn DE (1999). Stimulation of expression for the adenosine A2A receptor gene by hypoxia in PC12 cells. A potential role in cell protection. J Biol Chem 274, 20358-20365.
26. Laxson DD, Homans DC & Bache RJ (1993). Inhibition of adenosine-mediated coronary vasodilation exacerbates myocardial ischemia during exercise. Am J Physiol 265, H1471-H1477.
27. Lee SC, Mallet RT, Shizukuda Y, Williams AG Jr & Downey HF (1992). Canine coronary vasodepressor responses to hypoxia are attenuated but not abolished by 8-phenyltheophylline. Am J Physiol 262, H955-H960.
28. Leung GP, Man RY & Tse CM (2005). D-Glucose upregulates adenosine transport in cultured human aortic smooth muscle cells. Am J Physiol Heart Circ Physiol 288, H2756-H2762.
29. MacLean DA, Sinoway LI & Leuenberger U (1998). Systemic hypoxia elevates skeletal muscle interstitial adenosine levels in humans. Circulation 98, 1990-1992.
30. Mellemkjaer S & Nielsen-Kudsk JE (1994). Glibenclamide inhibits hypoxic relaxation of isolated porcine coronary arteries under conditions of impaired glycolysis. Eur J Pharmacol 270, 307-312.
31. Merrill GF, Downey HF & Jones CE (1986). Adenosine deaminase attenuates canine coronary vasodilation during systemic hypoxia. Am J Physiol 250, H579-H583.
32. Mertens S, Noll T, Spahr R, Krutzfeldt A & Piper HM (1990). Energetic response of coronary endothelial cells to hypoxia. Am J Physiol 258, H689-H694.
33. Moser GH, Schrader J & Deussen A (1989). Turnover of adenosine in plasma of human and dog blood. Am J Physiol 256, C799-C806.
34. + channel activation. Am J Physiol 265, H1289-H1293.
35. Nielsen JK, Djurhuus CB, Gravholt CH, Carus AC, Granild-Jensen J, Orskov H & Christiansen JS (2005). Continuous glucose monitoring in interstitial subcutaneous adipose tissue and skeletal muscle reflects excursions in cerebral cortex. Diabetes 54, 1635-1639.
36. Olsson RA & Pearson JD (1990). Cardiovascular purinoceptors. Physiol Rev 70, 761-845.
37. Pijls NH, De Bruyne B, Peels K, Van Der Voort PH, Bonnier HJ, Bartunek JKJ & Koolen JJ (1996). Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med 334, 1703-1708.
38. Rubin LJ, Johnson LR, Dodam JR, Dhalla AK, Magliola L, Laughlin MH & Jones AW (2000). Selective transport of adenosine into porcine coronary smooth muscle. Am J Physiol Heart Circ Physiol 279, H1397-H1410.
39. Rubio R, Berne RM & Dobson JG Jr (1973). Sites of adenosine production in cardiac and skeletal muscle. Am J Physiol 225, 938-953.
40. 2+, pH, and energetics in porcine coronary artery. Circ Res 86, 862-870.
41. Stepp DW, Van Bibber R, Kroll K & Feigl EO (1996). Quantitative relation between interstitial adenosine concentration and coronary blood flow. Circ Res 79, 601-610.
42. Tune JD, Richmond KN, Gorman MW, Olsson RA & Feigl EO (2000). Adenosine is not responsible for local metabolic control of coronary blood flow in dogs during exercise. Am J Physiol Heart Circ Physiol 278, H74-H84.
43. Van Wylen DG (1994). Effect of ischemic preconditioning on interstitial purine metabolite and lactate accumulation during myocardial ischemia. Circulat 89, 2283-2289.
44. Vasara E, Katharou I & Lazou A (2003). Myocardial adenosine does not correlate with the protection mediated by ischaemic or pharmacological preconditioning in rat heart. Clin Exp Pharmacol Physiol 30, 350-356.
45. Wadsworth RM (1994). Vasoconstrictor and vasodilator effects of hypoxia. Trends Pharmacol Sci 15, 47-53.
46. Wang T, Sodhi J, Mentzer RM Jr & Van Wylen DG (1994). Changes in interstitial adenosine during hypoxia: Relationship to oxygen supply: demand imbalance, and effects of adenosine deaminase. Cardiovasc Res 28, 1320-1325.